{
    "clinical_study": {
        "@rank": "67403", 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess potential interactions between intravenous (IV)\n      methamphetamine and oral bupropion."
        }, 
        "brief_title": "Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1", 
        "completion_date": "September 2003", 
        "condition": "Amphetamine-Related Disorders", 
        "condition_browse": {
            "mesh_term": "Amphetamine-Related Disorders"
        }, 
        "detailed_description": {
            "textblock": "This is a human laboratory clinical pharmacology study to assess potential interactions\n      between IV methamphetamine challenge and treatment with oral sustained-release bupropion."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Please contact site director for more details.\n\n        Exclusion Criteria:\n\n        Please contact site director for more details."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "20", 
        "firstreceived_date": "June 18, 2002", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00040040", 
            "org_study_id": "NIDA-CTO-0010-1"
        }, 
        "intervention": {
            "intervention_name": "Bupropion", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Methamphetamine", 
                "Bupropion"
            ]
        }, 
        "lastchanged_date": "February 8, 2007", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90024"
                    }, 
                    "name": "UCLA Integrated Substance Abuse Program"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77225"
                    }, 
                    "name": "University of Texas Health Science Center"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between IV Methamphetamine and Oral Bupropion", 
        "overall_official": {
            "affiliation": "National Institute on Drug Abuse (NIDA)", 
            "last_name": "Thomas Newton, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 1", 
        "primary_outcome": [
            {
                "measure": "Psychological effects"
            }, 
            {
                "measure": "BP, HR"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00040040"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "collaborator": {
                "agency": "University of California, Los Angeles", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "June 2002", 
        "study_design": "Allocation: Randomized, Masking: Double-Blind, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "August 2003"
    }, 
    "geocoordinates": {
        "UCLA Integrated Substance Abuse Program": "34.052 -118.244", 
        "University of Texas Health Science Center": "29.76 -95.369"
    }
}